Insulin-like growth factor binding protein 5 is associated with involution of the ventral prostate in castrated and finasteride-treated rats

Prostate

Volumn 35, Issue 4, 1998, Pages 273-278

  Thomas, Lynn N ^a   Cohen, Pinchas ^b   Douglas, Robert C ^a   Lazier, Catherine ^a   Rittmaster, Roger S ^a,c  

^a DALHOUSIE UNIVERSITY   (Canada)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c Victoria Building ^*  (Canada)

Author keywords

Androgen withdrawal; Apoptosis; Atrophy; IGF; IGFBP 5

Indexed keywords

ANDROGEN; DNA FRAGMENT; FINASTERIDE; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN 5;

ANIMAL TISSUE; APOPTOSIS; ARTICLE; ATROPHY; CASTRATION; CELL PROLIFERATION; IMMUNOHISTOCHEMISTRY; INVOLUTION; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTATE; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; TISSUE DISTRIBUTION;

ANIMALS; APOPTOSIS; DNA FRAGMENTATION; EPITHELIAL CELLS; FINASTERIDE; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 5; MALE; ORCHIECTOMY; PROSTATE; RATS; RATS, SPRAGUE-DAWLEY; REFERENCE VALUES;

EID: 0032101919     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(19980601)35:4<273::AID-PROS6>3.0.CO;2-H     Document Type: Article

References (36)

1. Mee S, Bigsby RM, Higgins SJ, Yoshiki S: The endocrinology and developmental biology of the prostate. Endocr Rev 1987;8: 338-362.
2. Kyprianou N , Isaacs JT: Activation of programmed cell death in the rat ventral prostate after castration. Endocrinology 1988;122: 552-562.
3. Rittmaster RS, Magor KE, Manning AP, Norman RW, Lazier CB: Differential effect of 5 alpha-reductase inhibition and castration on androgen-regulated gene expression in rat prostate. Mol Endocrinol 1991;5:1023-1029.
4. Rittmaster RS, Manning AP, Wright AS, Thomas LN, Whitefield S, Norman RW, Lazier CB, Rowden G: Evidence for atrophy and apoptosis in the ventral prostate of rats given the 5 alpha-reductase inhibitor finasteride. Endocrinology 1995;136:741-748.
5. Shao TC, Kong A, Marafelia P, Cunningham GR: Effects of finasteride on the rat ventral prostate. J Androl 1993;14:79-86.
6. Lamb JC, English H, Levandoski PL, Rhodes GR, Johnson RK, Isaacs JT: Prostatic involution in rats induced by a novel 5 alpha-reductase inhibitor, SK&F 105657: Role for testosterone in the androgenic response. Endocrinology 1992;130:685-694.
7. Cohick WS, Clemmons DR: The insulin-like growth factors. Annu Rev Physiol 1993;55:131-153.
8. Monget P, Monniaux D, Pisselet C, Durand P: Changes in insulin-like growth factor-I (IGF-I), IGF-II, and their binding proteins during growth and atresia of ovine ovarian follicles. Endocrinology 1993;132:1438-1446.
9. Krywicki RF, Figueroa JA, Jackson JG, Kozelsky TW, Shimasaki S, Von Hoff DD, Yee D: Regulation of insulin-like growth factor binding proteins in ovarian cancer cells by oestrogen. Eur J Cancer 1993;29A:2015-2019.
10. Kanety H, Madjar Y, Dagan Y, Levi J, Papa MZ, Pariente C, Goldwasser B, Karasik A: Serum insulin-like growth factor-binding protein-2 (IGFBP-2) is increased and IGFBP-3 is decreased in patients with prostate cancer: Correlation with serum prostate-specific antigen. J Clin Endocrinol Metab 1993;77:229-233.
11. Cohen P, Peehl DM, Graves HC, Rosenfeld RG: Biological effects of prostate specific antigen as an insulin-like growth factor binding protein-3 protease. J Endocrinol 1994;142:407-415.
12. Conover CA, Perry JE, Tindall DJ: Endogenous cathepsin D-mediated hydrolysis of insulin-like growth factor-binding proteins in cultured human prostatic carcinoma cells. J Clin Endocrinol Metab 1995;80:987-993.
13. Erickson GF, Nakatani A, Ling N, Shimasaki S: Localization of insulin-like growth factor-binding protein-5 messenger ribonucleic acid in rat ovaries during the estrous cycle. Endocrinology 1992;130:1867-1878.
14. Gavrieli Y, Sherman Y, Ben Sasson SA: Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992;119:493-501.
15. Kiefer MC, Schmid C, Waldvogel M, Schlapfer I, Futo E, Masiarz FR, Green K, Barr PJ, Zapf J: Recombinant human insulin-like growth factor binding proteins 4, 5, and 6: Biological and physiochemical characterization. Growth Regul 1993;3:56-59.
16. Conover CA, Kiefer MC: Regulation and biological effect of endogenous insulin-like growth factor binding protein-5 in human osteoblastic cells. J Clin Endocrinol Metab 1993;76:1153-1159.
17. Perkel VS, Mohan S, Baylink DJ, Linkhart TA: An inhibitory insulin-like growth factor binding protein (Hi-IGFBP) from human prostatic cell conditioned medium reveals N-terminal sequence identity with bone derived In-IGFBP. J Clin Endocrinol Metab 1990;71:533-535.
18. Ritvos O, Ranta T, Jalkanen J, Suikkari AM, Voultilainen R, Bohn H, Rutanen EM: Insulin-like growth factor (IGF) binding protein from human decidua inhibits the binding and biological action of IGF-I in cultured choriocarcinoma cells. Endocrinology 1988;122:2150-2157.
19. Burch WM, Correa J, Shively JE, Powell DR: The 25-kilodalton insulin-like growth factor (IGF)-binding protein inhibits both basal and IGF-I-mediated growth of chick embryo pelvic cartilage in vitro. J Clin Endocrinol Metab 1990;70:173-180.
20. Cheung PT, Smith EP, Shimasaki S, Ling N, Chernausek SD: Characterization of an insulin-like growth factor binding protein (IGFBP-4) produced by the B104 rat neuronal cell line: Chemical and biological properties and differential synthesis by sublines. Endocrinology 1991;129:1006-1015.
21. Conover CA, Ronk M, Lombana F, Powell DR: Structural and biological characterization of bovine insulin-like growth factor binding protein-3. Endocrinology 1990;127:2795-2803.
22. Frauman SG, Tsuzaki S, Moses AC: The binding characteristics and biological effects in FRTL5 cells of placental protein-12, an insulin-like growth factor-binding protein purified from human amniotic fluid. Endocrinology 1989;124:2289-2296.
23. Blat C, Delbe J, Villaudy J, Chatelain G, Golde A, Harel L: Inhibitory diffusible factor 45 bifunctional activity. As a cell growth inhibitor and as an insulin-like growth factor I-binding protein. J Biol Chem 1989;264:12449-12454.
24. Mohan S, Bautista CM, Wergedal J, Baylink DJ: Isolation of an inhibitory insulin-like growth factor (IGF) binding protein from bone cell-conditioned medium: A potential local regulator of IGF action. Proc Natl Acad Sci USA 1989;86:8338-8342.
25. Conover CA: Potentiation of insulin-like growth factor (IGF) action by IGF-binding protein-3: Studies of underlying mechanism. Endocrinology 1992;130:3191-3199.
26. Clemmons DR, Gardner LI: A factor contained in plasma is required for IGF binding protein-1 to potentiate the effect of IGF-I on smooth muscle cell DNA synthesis. J Cell Physiol 1990; 145:129-135.
27. Jones JI, Gockerman A, Busby WH Jr, Camacho Hubner C, Clemmons DR: Extracellular matrix contains insulin-like growth factor binding protein-5: Potentiation of the effects of IGF-I. J Cell Biol 1993;121:679-687.
28. Elgin RG, Busby WH, Clemmons DR: An insulin-like growth factor binding protein enhances the biological response to IGF-I. Proc Natl Acad Sci USA 1987;84:3254-3258.
29. Tilly JL, Kowalski KI, Johnson AL, Hsueh AJ: Involvement of apoptosis in ovarian follicular atresia and postovulatory regression. Endocrinology 1991;129:2799-2801.
30. Tilly JL: Ovarian follicular atresia: A model to study the mechanisms of physiological cell death. Endocr J 1993;1:67-72.
31. Mondschein JS, Etherton TD, Hammond JM: Characterization of insulin-like growth factor-binding proteins of porcine ovarian follicular fluid. Biol Reprod 1991;44:315-320.
32. Howard HJ, Ford JJ: Insulin-like growth factor binding proteins in fluid of developing follicles: Potential intra-ovarian regulators of steroidogenesis. Biol Reprod [Suppl] 1991;44:152.
33. Adashi EY, Resnick CE, Hernandez ER, Hurwitz A, Rosenfeld RG: Follicle-stimulating hormone inhibits the constitutive release of insulin-like growth factor binding proteins by cultured rat ovarian granulosa cells. Endocrinology 1990;126:1305-1307.
34. Erickson GF, Li D, Sadrkhanloo R, Liu XJ, Shimasaki S, Ling N: Extrapituitary actions of gonadotropin-releasing hormone: Stimulation of insulin-like growth factor-binding protein-4 and atresia. Endocrinology 1994;134:1365-1372.
35. Onoda N, Li D, Mickey G, Erickson G, Shimasaki S: Gonadotropin-releasing hormone overcomes follicle-stimulating hormone's inhibition of insulin-like growth factor-5 synthesis and promotion of its degradation in rat granulosa cells. Mol Cell Endocrinol 1995;110:17-25.
36. Shimasaki S, Shimonaka M, Zhang H, Ling N: Identification of five different insulin-like growth factor binding proteins (IGFBPs) from adult rat serum and molecular cloning of a novel IGFBP-5 in rat and human. J Biol Chem 1991;266:10646-10653.